HIGHLIGHTS
- who: Yangying Hu and colleagues from the Department of Thyroid and Breast Diagnosis and Treatment Center, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, Zhejiang, China have published the research: HMGB3 Targeted by miR-145-5p Impacts Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells, in the Journal: Computational and Mathematical Methods in Medicine of 10/Nov/2022
- what: In this research, the roles of HMGB3 and its upstream regulatory_gene miR-145-5p in BC cells were analyzed by bioinformatics analysis and cellular molecular experiments.
- how: The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.